Top Markets
Coin of the day
Johnson & Johnson Johnson & Johnson

Johnson & Johnson

JNJ
Rank in Stocks #23
Johnson & Johnson is a holding company, which engages in the research,... Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Share Price
$267.84
Market Cap
$645.47B
Change (1 day)
-0.63%
Change (1 year)
51.68%
Country
US
Trade Johnson & Johnson (JNJ)

Category

Revenue for Johnson & Johnson (JNJ)
Revenue in Jun 2026 TTM: $97.93B
According to Johnson & Johnson latest financial reports the company's current revenue (TTM) is $97.93B. In 2024 the company made a revenue of $88.82B an increase over the revenue in the year 2023 that was $85.16B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Johnson & Johnson from 2000 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $97.93B 3.97%
2025 $94.19B 6.05%
2024 $88.82B 4.30%
2023 $85.16B 8.15%
2022 $78.74B -4.65%
2021 $82.58B 0.64%
2019 $82.06B 0.59%
2018 $81.58B 6.71%
2017 $76.45B 6.34%
2016 $71.89B 2.59%
2015 $70.07B -5.73%
2014 $74.33B 4.23%
2013 $71.31B 6.08%
2012 $67.22B 3.37%
2011 $65.03B 5.59%
2010 $61.59B -0.50%
2009 $61.90B -2.90%
2008 $63.75B 4.34%
2007 $61.10B 14.57%
2006 $53.32B 5.56%
2005 $50.51B 6.69%
2004 $47.35B 13.10%
2003 $41.86B 15.33%
2002 $36.30B 12.32%
2001 $32.32B 10.78%
2000 $29.17B 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$79.67B -18.65%
US
$64.39B -34.25%
US
$77.52B -20.84%
CH
$66.40B -32.20%
US
$56.26B -42.55%
CH